| Renu Chalasani, MD | |
|
11111 Research Blvd #475, Austin, TX 78759-5283 | |
| (512) 338-8181 | |
| (512) 338-8366 |
| Full Name | Renu Chalasani |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 11111 Research Blvd #475, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174538227 | NPI | - | NPPES |
| 160047376 | Medicaid | TX | |
| 040540901 | Medicaid | TX | |
| 040540903 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | K5854 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Regional Clinic Pa | 3072507789 | 349 |
News Archive
Springer, a leading global scientific publisher, is launching a new book series entitled Trends in Augmentation of Human Performance. The series will focus on the enhancement of human skills, attributes and competencies through the use of technology, medicine and therapy.
In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.
Roche announced today, that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.
Durata Therapeutics today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts, including 1,125,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount.
Ever since the epidemic of cocaine and crack use that began in the 1980s, researchers and doctors have been concerned about the development of children born to women who used cocaine during their pregnancy.
› Verified 2 days ago
| Entity Name | Austin Regional Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821157579 PECOS PAC ID: 3072507789 Enrollment ID: O20040414000198 |
News Archive
Springer, a leading global scientific publisher, is launching a new book series entitled Trends in Augmentation of Human Performance. The series will focus on the enhancement of human skills, attributes and competencies through the use of technology, medicine and therapy.
In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.
Roche announced today, that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.
Durata Therapeutics today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts, including 1,125,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount.
Ever since the epidemic of cocaine and crack use that began in the 1980s, researchers and doctors have been concerned about the development of children born to women who used cocaine during their pregnancy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renu Chalasani, MD Po Box 26726, Austin, TX 78755-0726 Ph: (512) 407-8686 | Renu Chalasani, MD 11111 Research Blvd #475, Austin, TX 78759-5283 Ph: (512) 338-8181 |
News Archive
Springer, a leading global scientific publisher, is launching a new book series entitled Trends in Augmentation of Human Performance. The series will focus on the enhancement of human skills, attributes and competencies through the use of technology, medicine and therapy.
In what appears to be a disappointing outcome, trials of a new gel designed for women to protect themselves from the AIDS virus were stopped this week when researchers found that women using it became infected at a higher rate than women not using it.
Roche announced today, that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to Elecsys ß-Amyloid (1-42) CSF and Elecsys Phospho-Tau (181P) CSF.
Durata Therapeutics today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts, including 1,125,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount.
Ever since the epidemic of cocaine and crack use that began in the 1980s, researchers and doctors have been concerned about the development of children born to women who used cocaine during their pregnancy.
› Verified 2 days ago
Dr. Chris C Hart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9805 Brodie Ln, Austin, TX 78748 Phone: 512-462-1936 Fax: 512-394-9388 | |
Dr. Robert C Johnston, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12200 Renfert Way Ste G-3, Austin, TX 78758 Phone: 512-821-2540 Fax: 512-973-3533 | |
Dr. Keikhosrow M Kavoussi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4303 James Casey St, Suite A, Austin, TX 78745 Phone: 512-444-1414 Fax: 512-444-5621 | |
Dr. Andrea L. Campaigne, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way Ste 250, Austin, TX 78758 Phone: 512-994-2662 Fax: 512-406-6202 | |
Jonathan Edmond Pepper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6611 River Place Blvd Ste 202, Austin, TX 78730 Phone: 512-473-8300 | |
Akua Tiwaa Afriyie-gray, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 303, Austin, TX 78723 Phone: 512-324-0970 | |
Mr. Sasan Askari, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4007 James Casey St, Suite A-250, Austin, TX 78745 Phone: 512-444-2111 Fax: 512-444-2114 |